10-Q 1 ef20030087_10q.htm 10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2024

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______________ to _______________

Commission file number: 001-37763

TURNING POINT BRANDS, INC.
(Exact name of registrant as specified in its charter)

Delaware
 
20-0709285
(State or other jurisdiction of Incorporation or organization)
 
(I.R.S. Employer Identification No.)

5201 Interchange Way, Louisville, KY
 
40229
(Address of principal executive offices)
 
(Zip Code)

(502) 778-4421
(Registrant’s telephone number, including area code)

Former name, former address and former fiscal year, if changed since last report: not applicable

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value
TPB
New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes      No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes      No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
 
Accelerated filer
Non-accelerated filer
 
Smaller reporting company
Emerging growth company
     

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes      No 

At July 26, 2024, there were 17,714,070 shares outstanding of the registrant’s voting common stock, par value $0.01 per share.



TURNING POINT BRANDS, INC.
TABLE OF CONTENTS

   
Page No.
PART I—FINANCIAL INFORMATION
 
   
 
ITEM 1
Financial Statements (Unaudited)
 
       
   
5
       
   
6
       
   
7
       
   
8
 

 
   
9
       
    Consolidated Statements of Changes in Stockholders’ Equity for the six months ended June 30, 2024 and 2023 10
 
     
   
11
       
 
ITEM 2
33
       
 
ITEM 3
45
       
 
ITEM 4
46
       
PART II—OTHER INFORMATION
 
   
 
ITEM 1
47
       
 
ITEM 1A
47
       
 
ITEM 2
47
   
 
 
ITEM 3
47
       
 
ITEM 4
47
       
 
ITEM 5
47
       
 
ITEM 6
48
       
  49

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (this “Quarterly Report”), contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as “anticipate,” “believe,” “expect,” “intend,” “plan,” and “will” or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, and depend on circumstances, that may or may not occur in the future. As a result, actual events may differ materially from those expressed in, or suggested by, the forward-looking statements. Any forward-looking statement made by Turning Point Brands, Inc. (“TPB”), in this Quarterly Report on Form 10-Q speaks only as of the date hereof. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict these events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to:


declining sales of tobacco products, and expected continuing decline of sales in the tobacco industry overall;

our dependence on a small number of third-party suppliers and producers;

the possibility that we will be unable to identify or contract with new suppliers or producers in the event of a supply or product disruption, as well as other supply chain concerns, including delays in product shipments and increases in freight cost;

the possibility that our licenses to use certain brands or trademarks will be terminated, challenged or restricted;

failure to maintain consumer brand recognition and loyalty of our customers;

our reliance on relationships with several large retailers and national chains for distribution of our products;

intense competition and our ability to compete effectively;

competition from illicit sources and the damage caused by illicit products to our brand equity;
 
contamination of our tobacco supply or products;

uncertainty and continued evolution of the markets for our products;

complications with the design or implementation of our new enterprise resource planning system could adversely impact our business and operations;

substantial and increasing regulation and changes in U.S. Food and Drug Administration (“FDA”) enforcement priorities;

regulation or marketing denials of our products by the FDA, which has broad regulatory powers;

many of our products contain nicotine, which is considered to be a highly addictive substance;

requirement to maintain compliance with master settlement agreement escrow account;

possible significant increases in federal, state and local municipal tobacco- and nicotine-related taxes;

our products are marketed pursuant to a policy of FDA enforcement priorities which could change, and our products could become subject to increased regulatory burdens by the FDA;

uncertainty related to the PMTA application process;

our products are subject to developing and unpredictable regulation, such as court actions that impact obligations;

increase in state and local regulation of our products has been proposed or enacted;

increase in tax of our products could adversely affect our business;

sensitivity of end-customers to increased sales taxes and economic conditions, including as a result of inflation and other declines in purchasing power;

possible increasing international control and regulation;

failure to comply with environmental, health and safety regulations;

imposition of significant tariffs on imports into the U.S.;

the scientific community’s lack of information regarding the long-term health effects of certain substances contained in some of our products;

significant product liability litigation;

our amount of indebtedness;

the terms of our indebtedness, which may restrict our current and future operations;
 
our ability to establish and maintain effective internal controls over financial reporting;

identification of material weaknesses in our internal control over financial reporting, which, if not remediated appropriately or timely, could result in loss of investor confidence and adversely impact our stock price;

our certificate of incorporation and bylaws, as well as Delaware law and certain regulations, could discourage or prohibit acquisition bids or merger proposals, which may adversely affect the market price of our common stock;

our certificate of incorporation limits the ownership of our common stock by individuals and entities that are Restricted Investors. These restrictions may affect the liquidity of our common stock and may result in Restricted Investors (as defined in our Certificate of Incorporation) being required to sell or redeem their shares at a loss or relinquish their voting, dividend and distribution rights;

future sales of our common stock in the public market could reduce our stock price, and any additional capital raised by us through the sale of equity or convertible securities may dilute your ownership in us;


we may issue preferred stock whose terms could adversely affect the voting power or value of our common stock;

our business may be damaged by events outside of our suppliers’ control, such as the impact of epidemics (e.g., coronavirus), political upheavals, or natural disasters;

adverse impact of climate change;

our reliance on information technology;

cybersecurity and privacy breaches, which have increased in part due to artificial intelligence;

failure to manage our growth;

failure to successfully integrate our acquisitions or otherwise be unable to benefit from pursuing acquisitions;

fluctuations in our results;

exchange rate fluctuations;

adverse U.S. and global economic conditions;

departure of key management personnel or our inability to attract and retain talent;

infringement on or misappropriation of our intellectual property;

third-party claims that we infringe on their intellectual property; and

failure to meet expectations relating to environmental, social and governance factors.

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

Turning Point Brands, Inc.
Consolidated Balance Sheets
(dollars in thousands except share data)

   
(unaudited)
       
    June 30,     December 31,  
ASSETS
 
2024
   
2023
 
Current assets:
           
Cash
 
$
142,159
   
$
117,886
 
Accounts receivable, net of allowances of $54 in 2024 and $78 in 2023
   
12,557
     
9,989
 
Inventories, net
   
102,333
     
98,960
 
Other current assets
   
32,688
     
40,781
 
Total current assets
   
289,737
     
267,616
 
Property, plant, and equipment, net
   
26,441
     
25,300
 
Deferred income taxes
   
1,177
     
1,468
 
Right of use assets
   
10,305
     
11,480
 
Deferred financing costs, net
   
2,145
     
2,450
 
Goodwill
   
136,307
     
136,250
 
Other intangible assets, net
   
79,393
     
80,942
 
Master Settlement Agreement (MSA) escrow deposits
   
28,407
     
28,684
 
Other assets
   
17,644
     
15,166
 
Total assets
 
$
591,556
   
$
569,356
 
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
Accounts payable
 
$
11,919
   
$
8,407
 
Accrued liabilities
   
30,428
     
33,635
 
Current portion of long-term debt
    118,470       58,294  
Total current liabilities
   
160,817
     
100,336
 
Notes payable and long-term debt
   
247,960
     
307,064
 
Lease liabilities
   
8,834
     
9,950
 
Total liabilities
  $
417,611
    $
417,350
 
                 
Commitments and contingencies
           
                 
Stockholders’ equity:
               
Preferred stock, $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-
   
     
 
Common stock, voting, $0.01 par value; authorized shares, 190,000,000; 20,126,521 issued shares and 17,703,166 outstanding shares at June 30, 2024, and 19,922,137 issued shares and 17,605,677 outstanding shares at December 31, 2023
   
201
     
199
 
Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000; issued and outstanding shares -0-
   
     
 
Additional paid-in capital
   
121,948
     
119,075
 
Cost of repurchased common stock (2,423,355 shares at June 30, 2024 and 2,316,460 shares December 31, 2023)
   
(81,144
)
   
(78,093
)
Accumulated other comprehensive loss
   
(3,072
)
   
(2,648
)
Accumulated earnings
   
134,917
     
112,443
 
Non-controlling interest
   
1,095
     
1,030
 
Total stockholders’ equity
   
173,945
     
152,006
 
Total liabilities and stockholders’ equity
 
$
591,556
   
$
569,356
 

The accompanying notes are an integral part of the consolidated financial statements.

Turning Point Brands, Inc.
Consolidated Statements of Income
(dollars in thousands except share and per share data)
(unaudited)


 
Three Months Ended
June 30,
   
Six Months Ended
June 30,
 
   
2024
   
2023
   
2024
   
2023
 
Net sales (1)
 
$
108,512
   
$
105,595
    $ 205,570     $ 206,551  
Cost of sales
   
54,671
     
53,117
      99,817       105,456  
Gross profit
   
53,841
     
52,478
      105,753       101,095  
Selling, general, and administrative expenses
   
32,753
     
31,933
      65,399       62,708  
Other operating income
    (1,674 )           (1,674 )      
Operating income
   
22,762
     
20,545
      42,028       38,387  
Interest expense, net
   
2,991
     
4,019
      6,470       8,029  
Investment loss
   
2,439
     
4,080
      2,320       8,879  
Gain on extinguishment of debt
          (600 )           (1,377 )
Income before income taxes
   
17,332
     
13,046
      33,238       22,856  
Income tax expense
   
4,415
     
3,338
      8,142       5,806  
Consolidated net income
   
12,917
     
9,708
      25,096       17,050  
Net (loss) income attributable to non-controlling interest
   
(87
)
   
(217
)
    82       (472 )
Net income attributable to Turning Point Brands, Inc.
 
$
13,004
   
$
9,925
    $
25,014     $
17,522  
                                 
Basic income per common share:
                               
Net income attributable to Turning Point Brands, Inc.
 
$
0.74
   
$
0.56
    $
1.42     $
1.00  
Diluted income per common share:
                               
Net income attributable to Turning Point Brands, Inc.
 
$
0.68
   
$
0.53
    $
1.31     $
0.94  
Weighted average common shares outstanding:
                               
Basic
   
17,656,732
     
17,584,241
      17,655,713       17,556,030  
Diluted
   
20,156,854
     
20,409,943
      20,160,139       20,538,947  

(1) Net sales include excise taxes billed to customers of $0.8 million and $1.2 million for the three months ended June 30, 2024 and 2023, respectively.  Net sales include excise taxes billed to customer of $1.5 million and $2.4 million for the six months ended June 30, 2024 and 2023, respectively.

The accompanying notes are an integral part of the consolidated financial statements.

Turning Point Brands, Inc.
Consolidated Statements of Comprehensive Income
(dollars in thousands)
(unaudited)


 
Three Months Ended
June 30
 
   
2024
   
2023
 
Consolidated net income
 
$
12,917
   
$
9,708
 
                 
Other comprehensive income (loss), net of tax
               
Unrealized loss on MSA investments, net of tax of $4 in 2024 and $116 in 2023
   
(15
)
   
(365
)
Foreign currency translation, net of tax of $0 in 2024 and 2023
   
(26
)
   
(169
)
Unrealized gain (loss) on derivative instruments, net of tax of $4 in 2024 and $150 in 2023
   
15
     
(472
)
Unrealized loss on captive investments, net of tax of $0 in 2024
    (7 )      
     
(33
)
   
(1,006
)
Consolidated comprehensive income
   
12,884
     
8,702
 
Comprehensive loss attributable to non-controlling interest
   
(87
)
   
(217
)
Comprehensive income attributable to Turning Point Brands, Inc.
 
$
12,971
   
$
8,919
 


 
Six Months Ended
June 30,
 
   
2024
   
2023
 
Consolidated net income
 
$
25,096
   
$
17,050
 
                 
Other comprehensive income (loss), net of tax
               
Unrealized (loss) gain on MSA investments, net of tax of $19 in 2024 and $60 in 2023
   
(257
)
   
188
 
Foreign currency translation, net of tax of $0 in 2024 and 2023
   
(13
)
   
(248
)
Unrealized loss on derivative instruments, net of tax of $53 in 2024 and $259 in 2023
   
(171
)
   
(815
)
     
(441
)
   
(875
)
Consolidated comprehensive income
   
24,655
     
16,175
 
Comprehensive income (loss) attributable to non-controlling interest
   
82
     
(472
)
Comprehensive income attributable to Turning Point Brands, Inc.
 
$
24,573
   
$
16,647
 

The accompanying notes are an integral part of the consolidated financial statements.

Turning Point Brands, Inc.
Consolidated Statements of Cash Flows
(dollars in thousands)
(unaudited)


 
Six Months Ended
June 30,
 
   
2024
   
2023
 
Cash flows from operating activities:
           
Consolidated net income
 
$
25,096
   
$
17,050
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
Gain on extinguishment of debt
   
     
(1,377
)
Loss on sale of property, plant, and equipment
   
7
     
44
 
Loss on MSA investments
    6        
Depreciation and other amortization expense
   
1,916
     
1,535
 
Amortization of other intangible assets
   
1,559
     
1,542
 
Amortization of deferred financing costs
   
1,393
     
1,225
 
Deferred income tax expense
   
363
     
659
 
Stock compensation expense
   
3,951
     
2,836
 
Noncash lease income
   
(85
)
   
(29
)
Loss on investments
   
2,722
     
8,989
 
Changes in operating assets and liabilities:
               
Accounts receivable
   
(2,489
)
   
456
 
Inventories
   
(3,218
)
   
(5,146
)
Other current assets
   
4,863
     
3,769
 
Other assets
   
(279
)
   
(4,548
)
Accounts payable
   
3,565
     
2,500
 
Accrued liabilities and other
   
(3,293
)
   
(1,972
)
Net cash provided by operating activities
 
$
36,077
   
$
27,533
 
                 
Cash flows from investing activities:
               
Capital expenditures
 
$
(2,858
)
 
$
(2,993
)
Purchases of investments
    (7,934 )    
 
Proceeds from sale of investments
    3,314        
Purchases of non-marketable equity investments
    (500 )      
Proceeds on the sale of property, plant and equipment
   
2
     
3
 
Restricted cash, MSA escrow deposits
    4        
Net cash used in investing activities
 
$
(7,972
)
 
$
(2,990
)
                 
Cash flows from financing activities:
               
Convertible Senior Notes repurchased
  $     $ (27,357 )
Proceeds from call options
          70  
Payment of financing costs
    (133 )      
Payment of dividends
   
(2,407
)
   
(2,209
)
Exercise of options
   
900
     
406
 
Redemption of options
    (4 )     (346 )
Redemption of restricted stock units
    (840 )      
Redemption of performance based restricted stock units
    (1,212 )     (995 )
Common stock repurchased
   
(3,051
)
   
 
Net cash used in financing activities
 
$
(6,747
)
 
$
(30,431
)
                 
Net increase (decrease) in cash
 
$
21,358
   
$
(5,888
)
Effect of foreign currency translation on cash
 
$
(76
)
 
$
(8
)
                 
Cash, beginning of period:
               
Unrestricted
 
$
117,886
   
$
106,403
 
Restricted
   
4,929
     
4,929
 
Total cash at beginning of period
 
$
122,815
   
$
111,332
 
                 
Cash, end of period:
               
Unrestricted
 
$
142,159
   
$
100,507
 
Restricted
   
1,938
     
4,929
 
Total cash at end of period
 
$
144,097
   
$
105,436
 
                 
Supplemental schedule of noncash investing activities:
               
Accrued capital expenditures
 
$
   
$
42
 
                 
Supplemental schedule of noncash financing activities:
               
Dividends declared not paid
 
$
1,279
   
$
1,188
 

The accompanying notes are an integral part of the consolidated financial statements.

Turning Point Brands, Inc.
Consolidated Statements of Changes in Stockholders’ Equity
For the Three Months Ended June 30, 2024 and 2023
(dollars in thousands except share data)
(unaudited)

                      Cost of     Accumulated                    
          Common     Additional    
Repurchased
    Other          
Non-
       
    Voting     Stock,     Paid-In    
Common
   
Comprehensive
    Accumulated     Controlling        

 
Shares
   
Voting
   
Capital
   
Stock
   
Income (Loss)
   
Earnings
   
Interest
   
Total
 
Beginning balance April 1, 2024
   
17,627,817
   
$
200
   
$
119,792
   
$
(80,172
)
 
$
(3,048
)
 
$
123,192
   
$
1,191
   
$
161,155
 
                                                                 
Unrealized loss on MSA investments, net of tax of $4
   
     
     
     
     
(15
)
   
     
     
(15
)
Unrealized gain on derivative instruments, net of tax of $4
                            15                   15  
Foreign currency translation, net of tax of $0
   
     
     
     
     
(17
)
   
     
(9
)
   
(26
)
Unrealized loss on investments, net of tax of $0
                            (7 )                 (7 )
Stock compensation expense
   
     
     
1,889
     
     
     
     
     
1,889
 
Exercise of options
   
61,249
     
     
897
     
     
     
     
     
897
 
Redemption of options
    (168 )           (4 )                               (4 )
Cost of repurchased common stock
    (34,350 )                 (972 )                       (972 )
Issuance of performance based restricted stock units
    3,214                                            
Issuance of restricted stock units
    68,343       1       78                               79  
Redemption of restricted stock units
    (22,939 )           (704 )                             (704 )
Dividends
   
     
     
     
     
     
(1,279
)
   
     
(1,279
)
Net income
   
     
     
     
     
     
13,004
     
(87
)
   
12,917
 
Ending balance June 30, 2024
   
17,703,166
   
$
201
   
$
121,948
   
$
(81,144
)
 
$
(3,072
)
 
$
134,917
   
$
1,095
   
$
173,945
 
                                                                 
                                                                 
Beginning balance April 1, 2023
   
17,585,529
   
$
199
   
$
113,477
   
$
(78,093
)
 
$
(2,234
)
 
$
85,133
   
$
1,452
   
$
119,934
 
                                                                 
Unrealized loss on MSA investments, net of tax of $116
   
     
     
     
     
(365
)
   
           
(365
)
Unrealized loss on derivative instruments, net of tax of $150
   
                        (472 )                 (472 )
Foreign currency translation, net of tax of $0
                            (110 )           (59 )     (169 )
Stock compensation expense
   
     
     
2,093
     
     
     
           
2,093
 
Exercise of options
   
4,416
     
     
49
     
     
     
           
49
 
Redemption of options
    (15,985 )           (346 )                             (346 )
Issuance of performance restricted stock units 
    26,050             78                               78  
Redemption of performance restricted stock units
    (4,431 )           (105 )                             (105 )
Settlement of call options, net of tax of $9
                26                   -       -       26  
Dividends
   
     
     
     
     
     
(1,185
)
         
(1,185
)
Net income
   
     
     
     
     
     
9,925
      (217 )    
9,708
 
Ending balance June 30, 2023
   
17,595,579
   
$
199
   
$
115,272
   
$
(78,093
)
 
$
(3,181
)
 
$
93,873
   
$
1,176
   
$
129,246
 

The accompanying notes are an integral part of the consolidated financial statements.
Turning Point Brands, Inc.
Consolidated Statements of Changes in Stockholders’ Equity
For the Six Months Ended June 30, 2024 and 2023
(dollars in thousands except share data)
(unaudited)

                     
    Accumulated                    
          Common     Additional    
Cost of
    Other          
Non-
       
    Voting     Stock,     Paid-In    
Repurchased
   
Comprehensive
    Accumulated     Controlling        

 
Shares
   
Voting
   
Capital
   
Common Stock
   
Income (Loss)
   
Earnings
   
Interest
   
Total
 
Beginning balance January 1, 2024
   
17,605,677
   
$
199
   
$
119,075
   
$
(78,093
)
 
$
(2,648
)
 
$
112,443
   
$
1,030
   
$
152,006
 
                                                                 
Unrealized loss on MSA investments, net of tax of $19
   
     
     
     
     
(257
)
   
     
     
(257
)
Unrealized loss on derivative instruments, net of tax of $53
                            (171 )                 (171 )
Foreign currency translation, net of tax of $0
   
     
     
     
     
4
     
     
(17
)
   
(13
)
Stock compensation expense
   
     
     
3,951
     
     
     
     
     
3,951
 
Exercise of options
   
61,447
     
     
900
     
     
     
     
     
900
 
Redemption of options
    (168 )           (4 )                             (4 )
Cost of repurchased common stock
    (106,895 )                 (3,051 )                       (3,051 )
Issuance of performance based restricted stock units
    129,323       1                                     1  
Redemption of performance based restricted stock units
    (48,177 )           (1,212 )                             (1,212 )
Issuance of restricted stock units
    90,040       1       78